From the launch ledger: Lexapro drug induced psychosis did not leave the bonding curve. Its peak market cap was about $3,476. That is a launch-scale figure, not a risk rating.
Check Lexapro drug induced psychosis liveSolscan| Creator | 72rwQa2a…VEuq4g |
|---|---|
| X account | not linked |
| Launch market cap | $3,476 |
| Peak market cap | $3,476 |
| Launch multiple | 0.0x |
| Graduated | no |
Whether a holder can exit. That needs a live read of authority, holder concentration and exit depth, which is the check button above. Graduation means clearing a bar that almost every launch fails.
What these numbers are. CoinCheck's 94.6% aggregate is a bonding-curve graduation predictor over 79,519 resolved calls. It is not a rug-detection accuracy rate, and its bullish bucket scores 1%.
What a launch figure is not. A multiple of launch market cap describes how far a launch moved. It is not a risk score, and graduating is not a safety endorsement: the large majority of launches never leave the curve.
Not built. Cross-chain wallet clustering and LP-unlock alerts are not implemented and are marked as such on the features page.
Independence. No paid promotion. No ranking is bought.